← Leaderboards
Marvin J Miller
University Of Notre Dame
$13,460,176
Attributed
$14,317,515
Total exposure
8
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $978.4K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,317,515 · 8
By mechanism
R01$6,239,232 · 4
R37$5,201,890 · 1
T32$2,266,830 · 1
R21$407,413 · 1
R43$202,150 · 1
Top collaborators
- Mayland F Chang5 shared
- Scott J. Hecker2 shared
Most similar at University Of Notre Dame
Same institution · by research overlap
- Susan G Sheridan$880,945
- Antonio Simonetti$500,934
- Michael Wiescher$17,719,531
- Ani Aprahamian$9,615,339
- Philippe A Collon$6,277,866
Others in their field
Top investigators on “Chemistry”
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- David Heimbrook · Leidos Biomedical Research, Inc.$152,241,999
- Alan G Marshall · Florida State University$98,440,345
- Gregory S Boebinger · Florida State University$82,544,371
- Charles H Mielke · Florida State University$82,175,927
- Reshan Fernando · Research Triangle Institute$60,546,015
Research focus
ChemistryDesignLeadIn VitroMicrobeScaffoldPharmaceutical PreparationsToxic EffectIn VivoMycobacterium TuberculosisTuberculosisGrowthEvaluationCessation Of LifeDrug KineticsDrug ResistanceSamplingCollaborationsAntitubercular AgentsMetabolismPyridineMulti-Drug ResistanceMaximum Tolerated DoseResistant Strain
Grant awards (43)
Design, Syntheses and Studies of Novel Antituberculosis Agents$562,117
R37 · FY2025 · AI · contact PI
Design, Syntheses and Studies of Novel Antituberculosis Agents$562,125
R37 · FY2024 · AI · contact PI
Design, Syntheses and Studies of Novel Antituberculosis Agents$562,443
R37 · FY2023 · AI · contact PI
Design, Syntheses and Studies of Novel Antituberculosis Agents$562,712
R37 · FY2022 · AI · contact PI
Design, Syntheses and Studies of Novel Antituberculosis Agents$590,748
R37 · FY2021 · AI · contact PI
Design, Syntheses and Studies of Novel Antituberculosis Agents$466,899
R37 · FY2020 · AI · contact PI
Design, Syntheses and Studies of Novel Antituberculosis Agents$466,899
R37 · FY2019 · AI · contact PI
Design, Syntheses and Studies of Novel Antituberculosis Agents$466,899
R37 · FY2018 · AI · contact PI
Design, Syntheses and Studies of Novel Antituberculosis Agents$466,899
R37 · FY2017 · AI · contact PI
Design, Syntheses and Studies of Novel Antituberculosis Agents$494,149
R37 · FY2016 · AI · contact PI
Chemistry-Biochemistry-Biology Training Program at Notre Dame$271,579
T32 · FY2016 · GM
Structural Modification of Daptomycin to Allow Anti-Pseudomonas Activity$202,150
R43 · FY2016 · AI · contact PI
Chemistry-Biochemistry-Biology Training Program at Notre Dame$273,682
T32 · FY2015 · GM
Design, Syntheses and Studies of Novel Antituberculosis Agents$375,170
R01 · FY2014 · AI · contact PI
Chemistry-Biochemistry-Biology Training Program at Notre Dame$270,804
T32 · FY2014 · GM
Design, Syntheses and Studies of Novel Antituberculosis Agents$352,572
R01 · FY2013 · AI · contact PI
Chemistry-Biochemistry-Biology Training Program at Notre Dame$267,927
T32 · FY2013 · GM
Molecular Archaeology: Vintage Beta Lactams for Resistant Gram Negative Infectio$191,798
R21 · FY2013 · AI
Design, Syntheses and Studies of Novel Antituberculosis Agents$374,988
R01 · FY2012 · AI · contact PI
Chemistry-Biochemistry-Biology Training Program at Notre Dame$223,273
T32 · FY2012 · GM
Molecular Archaeology: Vintage Beta Lactams for Resistant Gram Negative Infectio$215,615
R21 · FY2012 · AI
Design, Syntheses and Studies of Novel Antituberculosis Agents$374,906
R01 · FY2011 · AI · contact PI
Chemistry-Biochemistry-Biology Interface Training Program at Notre Dame$176,752
T32 · FY2011 · GM · contact PI
Design, Syntheses and Studies of Novel Antituberculosis Agents$391,102
R01 · FY2010 · AI · contact PI
Chemistry-Biochemistry-Biology Interface Training Program at Notre Dame$174,938
T32 · FY2010 · GM · contact PI
Chemistry-Biochemistry-Biology Interface Training Program at Notre Dame$174,056
T32 · FY2009 · GM · contact PI
Chemistry-Biochemistry-Biology Interface Training Program at Notre Dame$174,056
T32 · FY2009 · GM · contact PI
Chemistry-Biochemistry-Biology Interface Training Program at Notre Dame$173,175
T32 · FY2008 · GM · contact PI
Derivatization/Functionalization of Natural Product(RMI)$319,817
R01 · FY2007 · GM · contact PI
Design/Syntheses/Studies/Novel Antituberculosis Agents$314,749
R01 · FY2007 · AI · contact PI
Chemistry-Biochemistry-Biology Interface Training Program at Notre Dame$86,588
T32 · FY2007 · GM · contact PI
Novel Derivatization/Functionalization of Natural Produc$330,148
R01 · FY2006 · GM · contact PI
Design/Syntheses/Studies/Novel Antituberculosis Agents$324,150
R01 · FY2006 · AI · contact PI
Bioactive Compounds from Acylnitroso Cycloadducts$287,120
R01 · FY2006 · GM · contact PI
Derivatization/Functionalization:Natural Product(RMI)$352,455
R01 · FY2005 · GM
Design/Syntheses/Studies/Novel Antituberculosis Agents$331,951
R01 · FY2005 · AI
Bioactive Compounds from Acylnitroso Cycloadducts$294,030
R01 · FY2005 · GM
Design/Syntheses/Studies/Novel Antituberculosis Agents$344,451
R01 · FY2004 · AI
Bioactive Compounds from Acylnitroso Cycloadducts$294,030
R01 · FY2004 · GM
Bioactive Compounds from Acylnitroso Cycloadducts$294,030
R01 · FY2003 · GM
DRUGS AND DELIVERY SYSTEMS FOR OPPORTUNISTIC INFECTIONS$303,270
R01 · FY2002 · AI
DRUGS AND DELIVERY SYSTEMS FOR OPPORTUNISTIC INFECTIONS$294,433
R01 · FY2001 · AI
DRUGS AND DELIVERY SYSTEMS FOR OPPORTUNISTIC INFECTIONS$285,860
R01 · FY2000 · AI